Get notified when TPST files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Departure Of Cfo (new) — Chief Financial Officer resigned effective June 5, 2026, with no external replacement announced.
- Nasdaq Compliance Deficiency (new) — Company violated Nasdaq listing rules due to board vacancies and is not eligible for standard cure periods.
Tempest CFO resigns; company scrambles to fix Nasdaq board compliance after vacancies
Filed June 4, 2026 · Period ending May 29, 2026 · ~1 min read
Key Changes
-
high
CFO Nicholas Maestas resigned effective June 5, 2026. Internal controller Justin Trojanowski promoted to Principal Financial Officer while keeping his existing roles—no external CFO search announced.
Item 5.02 verify on EDGAR → -
high
Nasdaq notified Tempest on May 22 of listing rule violations due to multiple board vacancies. Company not eligible for standard cure periods and must submit compliance plan to exchange.
Item 5.02 verify on EDGAR → -
medium
Two new directors appointed June 4: Dr. John Yee (Apnimed exec) and Drake Richey (financial advisor). Both join Audit, Compensation, and Governance committees. Company says one more independent director needed for full compliance.
Item 5.02 verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.
Partner
Trade TPST commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify